EC Number | Application | Comment | Organism |
---|---|---|---|
3.5.3.18 | medicine | structure-based development of specific DDAH-1 inhibitors that might be useful in the therapeutic treatment of NOS dysfunction-related diseases | Bos taurus |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
3.5.3.18 | by sitting drop vapor diffusion, at 1.08-2.0 A resolution and at pH 6.3 and pH 9.0 | Bos taurus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.5.3.18 | L-citrulline | - |
Bos taurus | |
3.5.3.18 | L-homocysteine | - |
Bos taurus | |
3.5.3.18 | S-nitroso-L-homocysteine | - |
Bos taurus | |
3.5.3.18 | Zn2+ | - |
Bos taurus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.5.3.18 | Bos taurus | P56965 | - |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
3.5.3.18 | anion exchange chromatography and gel filtration chromatography | Bos taurus |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.5.3.18 | brain | - |
Bos taurus | - |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.5.3.18 | DDAH-1 | - |
Bos taurus |
3.5.3.18 | dimethylarginine dimethylaminohydrolase | - |
Bos taurus |